HealthEquity (NASDAQ:HQY) Posts Quarterly Earnings Results, Misses Estimates By $0.16 EPS

HealthEquity (NASDAQ:HQY - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.16), Zacks reports. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. The business had revenue of $311.80 million for the quarter, compared to analysts' expectations of $306.12 million. HealthEquity updated its FY 2026 guidance to 3.570-3.740 EPS.

HealthEquity Stock Up 0.3 %

Shares of NASDAQ:HQY traded up $0.28 on Friday, reaching $84.88. The company had a trading volume of 1,740,588 shares, compared to its average volume of 693,710. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The stock has a 50-day moving average price of $104.90 and a 200 day moving average price of $95.55. The stock has a market capitalization of $7.36 billion, a P/E ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on HQY shares. Raymond James lifted their price target on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Tuesday, February 25th. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research note on Tuesday, December 10th. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price on the stock. Barrington Research restated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of "Moderate Buy" and an average target price of $112.92.

Remove Ads

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.